{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:01:58Z","timestamp":1790866918268,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.neuropharm.2010.05.012","type":"journal-article","created":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T04:31:07Z","timestamp":1276489867000},"page":"380-387","source":"Crossref","is-referenced-by-count":64,"title":["T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor"],"prefix":"10.1016","volume":"59","author":[{"given":"Adrian","family":"Handforth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg E.","family":"Homanics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas F.","family":"Covey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathiresan","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Yeol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sakimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredricka C.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulfo","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2010.05.012_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0168-0102(97)00066-7","article-title":"Pharmacological profiles of generalized absence seizures in lethargic, stargazer and \u03b3-hydroxybutyrate-treated model mice","volume":"29","author":"Aizawa","year":"1997","journal-title":"Neuroscience Research"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.neuroscience.2008.09.052","article-title":"T-type calcium channels mediate rebound firing in intact deep cerebellar neurons","volume":"158","author":"Alvi\u0148a","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archneurol.2007.8","article-title":"Reduced Purkinje cell number in essential tremor: a postmortem study","volume":"65","author":"Axelrad","year":"2008","journal-title":"Archives of Neurology"},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2010.05.012_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.eplepsyres.2005.11.004","article-title":"Introduction to zonisamide","volume":"68","author":"Baulac","year":"2006","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF00231139","article-title":"Harmaline induced tremor. III. A combined simple units, horseradish peroxidase, and 2-deoxyglucose study of the olivocerebellar system in the rat","volume":"57","author":"Bernard","year":"1984","journal-title":"Experimental Brain Research"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib6","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.45.8.1523","article-title":"The effect of nimodipine on essential tremor","volume":"45","author":"Biary","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410410108","article-title":"Activation mapping in essential tremor with functional magnetic resonance imaging","volume":"41","author":"Bucher","year":"1997","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1212\/01.WNL.0000101722.95137.19","article-title":"Pilot trial of 1-octanol in essential tremor","volume":"62","author":"Bushara","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1476-5381.1996.tb15413.x","article-title":"Actions of long chain alcohols on GABAA and glutamate receptors: relation to in vivo effects","volume":"118","author":"Dildy-Mayfield","year":"1996","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1124\/mol.60.5.1121","article-title":"Block of cloned human T-type calcium channels by succinimide antiepileptic drugs","volume":"60","author":"Gomora","year":"2001","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s100720070069","article-title":"New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide","volume":"21","author":"Gunal","year":"2000","journal-title":"Neurological Sciences"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.22418","article-title":"Zonisamide for essential tremor: an evaluator-blinded study","volume":"24","author":"Handforth","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/jpet.103.060814","article-title":"NNC 55-0396 [(1 S,2 S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2, 3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels","volume":"309","author":"Huang","year":"2004","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.tins.2007.05.007","article-title":"Thalamic synchrony and dynamic regulation of global forebrain oscillations","volume":"30","author":"Huguenard","year":"2007","journal-title":"Trends in Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib15","first-page":"184","article-title":"Nicardipine versus propranolol in essential tumor","volume":"16","author":"Jim\u00e9nez-Jim\u00e9nez","year":"1994","journal-title":"Acta Neurologica (Napoli)"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0896-6273(01)00343-9","article-title":"Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking \u03b11G T-type Ca2+ channels","volume":"31","author":"Kim","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1059-1311(96)80104-X","article-title":"Mechanisms of T-type calcium channel blockade by zonisamide","volume":"5","author":"Kito","year":"1996","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/jnnp.73.4.400","article-title":"Essential tremor and cerebellar dysfunction: abnormal ballistic movements","volume":"73","author":"K\u00f6ster","year":"2002","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI200523625","article-title":"Genetic essential tremor in \u03b3-aminobutyric acidA receptor \u03b11 subunit knockout mice","volume":"115","author":"Kralic","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib20","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.2337\/db08-1763","article-title":"Selective T-type calcium channel blockade alleviates hyperalgesia in ob\/ob mice","volume":"58","author":"Latham","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/297406a0","article-title":"Electrophysiology of mammalian thalamic neurones in vitro","volume":"297","author":"Llin\u00e1s","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1113\/jphysiol.1981.sp013763","article-title":"Electrophysiology of mammalian inferior olivary neurones in vitro. Different types of voltage-dependent ionic conductances","volume":"315","author":"Llin\u00e1s","year":"1981","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/mds.20331","article-title":"Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications","volume":"20","author":"Martin","year":"2005","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2007.05.008","article-title":"Effects of zonisamide on experimental tremors in rats","volume":"14","author":"Miwa","year":"2008","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib26","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1073\/pnas.0601261103","article-title":"Specific T-type calcium channel isoforms are associated with distinct burst phenotypes in deep cerebellar nuclear neurons","volume":"103","author":"Molineux","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0028-3908(99)00013-1","article-title":"Blockade of Ba2+ current through human \u03b11E channels by two steroid analogs, (+)-ACN and (+)-ECN","volume":"38","author":"Nakashima","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib28","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1152\/jn.00243.2004","article-title":"Expression of distinct \u03b1 subunits of GABAA receptor regulates inhibitory synaptic strength","volume":"92","author":"Ortinski","year":"2004","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib29","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1016\/j.bmc.2006.01.005","article-title":"Synthesis and SAR studies of a novel series of T-type calcium channel blockers","volume":"14","author":"Park","year":"2006","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/jpet.108.145672","article-title":"Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs","volume":"328","author":"Perez-Reyes","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib31","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/01.anes.0000267601.09764.e6","article-title":"Mutation of \u03b11G T-type calcium channels in mice does not change anesthetic requirements for loss of the righting reflex and minimum alveolar concentration but delays the onset of anesthetic induction","volume":"106","author":"Petrenko","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0920-1211(89)90041-7","article-title":"Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant","volume":"3","author":"Rock","year":"1989","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib33","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1021\/jm800419w","article-title":"Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist","volume":"51","author":"Shipe","year":"2008","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00585623","article-title":"The effectiveness of different isomers of octanol as blockers of harmaline-induced tremor","volume":"414","author":"Sinton","year":"1989","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2008.06.038","article-title":"Lacosamide, the new anticonvulsant, effectively reduces harmaline-induced tremors in rats","volume":"589","author":"St\u00f6hr","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1152\/jn.1998.79.1.240","article-title":"Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents","volume":"79","author":"Todorovic","year":"1998","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib37","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/mol.54.5.918","article-title":"Enantioselective blockade of T-type Ca2+ current in adult rat sensory neurons by a steroid that lacks \u03b3-aminobutyric acid-modulatory activity","volume":"54","author":"Todorovic","year":"1998","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000116142","article-title":"Calcium channel blockers and essential tremor","volume":"27","author":"Topaktas","year":"1987","journal-title":"European Neurology"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s002130050809","article-title":"Positive allosteric modulators of the GABAA receptor: differential interaction of benzodiazepines and neuroactive steroids with ethanol","volume":"141","author":"Vanover","year":"1999","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib40","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1523\/JNEUROSCI.21-09-03009.2001","article-title":"GABAA receptor \u03b11 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons","volume":"21","author":"Vicini","year":"2001","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2005.02.006","article-title":"Zonisamide for absence seizures","volume":"64","author":"Wilfong","year":"2005","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.neuropharm.2010.05.012_bib42","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1021\/jm800830n","article-title":"Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels","volume":"51","author":"Yang","year":"2008","journal-title":"Journal of Medicinal Chemistry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810001371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810001371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T22:56:46Z","timestamp":1559170606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390810001371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0028390810001371"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.05.012","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}